查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美心肺氧合器市场预测至 2028 年 - 区域分析 - 按产品、应用、类型、年龄层和最终用途
市场调查报告书
商品编码
1360049

北美心肺氧合器市场预测至 2028 年 - 区域分析 - 按产品、应用、类型、年龄层和最终用途

North America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - By Product, Application, Type, Age Group, and End Use
出版日期: | 出版商: The Insight Partners | 英文 144 Pages | 订单完成后即时交付

价格

2022年北美心肺氧合器市值为2.6135亿美元，预计到2028年将达到3.3451亿美元。预计2022年至2028年复合年增长率为4.2%。

随着人口老化的增加，外科手术的增加正在推动北美心肺氧合器市场的发展

外科手术对于控制心血管疾病和肺部疾病等健康状况是必要的。在某些医疗情况下，如果不进行手术，就没有其他选择。根据美国国家生物技术资讯中心 (NCBI) 2020 年发表的一篇文章，全球每年进行约 3.1 亿例大型外科手术，其中 5000-6000 万例在美国进行。对心血管手术的高需求可归因于人口老化中心血管疾病发生率的增加。此外，对于患有严重肺损伤和未缓解的 COVID-19 相关呼吸衰竭的患者来说，肺移植可能是唯一有用的治疗选择。因此，随着心血管和肺移植手术数量的不断增加，该地区对心肺氧合器的需求也不断增加。

据世界卫生组织称，预计到 2050 年，60 岁及以上人口的比例将从 2015 年的 12% 增至 22%。心血管疾病仍然是 65 岁以上成年人死亡的主要原因。老化会导致心臟和血管，增加这些疾病的风险。因此，老年族群心血管疾病的盛行率促进了心肺氧合器市场的成长。

北美心肺氧合器市场概况

北美的心肺氧合器市场分为美国、加拿大和墨西哥。预计美国将成为该地区市场的最大贡献者。北美市场的成长归因于该地区心血管和呼吸系统疾病盛行率的上升。这增加了慢性阻塞性肺病、慢性支气管炎、充血性心臟衰竭等心肺疾病的发生率。例如，根据美国肺臟协会的数据，2020 年，美国约有1,250 万人被诊断出患有慢性阻塞性肺病、慢性支气管炎和肺气肿。此外，此类疾病的盛行率和发生率不断上升，导致大量患者群体中接受外科手术的数量增加推动了心肺氧合器市场的成长。例如，根据寿命健康系统发表的研究，美国每年进行约 50 万例心臟直视手术。此外，呼吸衰竭和传染病患者病率的增加预计将进一步创造对心肺氧合器的需求。

此外，心血管疾病盛行率的上升是全球死亡的主要原因，而氧合器可以在紧急情况下为挽救生命提供巨大帮助。根据世界卫生组织的数据，每年约有 1,790 万人因心血管疾病而丧生。此外，优惠的报销政策也有望为心肺氧合器的发展创造充足的机会。因此，心肺疾病盛行率和发病率的上升预计将在预测期内推动心肺氧合器市场的成长。

北美心肺氧合器市场收入及2028年预测（百万美元）

北美心肺氧合器市场细分

北美心肺氧合器市场分为产品、应用、类型、年龄层、最终用途和国家。根据产品，市场分为膜式氧合器和气泡式氧合器。 2022年，膜式氧合器细分市场将占据更大的市场。

根据应用，市场分为心臟和呼吸系统。到2022年，心臟细分市场将占据更大的市场份额。此外，心臟细分为急性心肌梗塞、心肌炎、移植后併发症、失代偿性心肌病变等。此外，呼吸系统又分为呼吸衰竭、急性呼吸窘迫症候群、肺栓塞、肺炎和 COVID-19。

根据类型，市场分为可重复使用心肺氧合器和一次性心肺氧合器。 2022 年，可重复使用心肺氧合器细分市场将占据更大的市场份额。

根据年龄组，市场分为成人、儿童和新生儿。 2022 年，成人细分市场占据最大的市场份额。

根据最终用途，市场分为医院和诊所、门诊手术中心等。 2022 年，医院和诊所细分市场占据最大市场份额。

根据国家/地区，市场分为美国、加拿大和墨西哥。 2022 年，美国占据市场份额主导地位。

洁定公司；利瓦诺瓦有限公司；美敦力公司；泰尔茂公司；尼普罗医疗公司；微创科学公司；点字生物医学工业、商业和代表有限公司；圣杯医疗有限公司；和 Fresenius Medical Care AG & Co KGaA 是该地区心肺氧合器市场的领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 北美心肺氧合器市场 - 按产品
    • 北美心肺氧合器市场 - 按应用
    • 北美心肺氧合器市场 - 按类型
    • 北美心肺氧合器市场 - 按年龄段
    • 北美心肺氧合器市场 - 按最终用途
    • 北美心肺氧合器市场 - 按国家/地区

第 2 章：北美心肺氧合器市场要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美心肺氧合器市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

专家意见

第 5 章：北美心肺氧合器市场 - 主要市场动态

  • 市场驱动因素
    • 心肺疾病发生率上升
    • 随着人口老化的激增，外科手术数量不断增加
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加儿科和新生儿患者心肺氧合器的使用
  • 未来的趋势
    • 便携式体外膜氧合在肺移植手术的应用
  • 影响分析

第 6 章：心肺氧合器市场 - 北美分析

  • 北美心肺氧合器市场收入预测与分析

第 7 章：北美心肺氧合器市场 - 收入和 2028 年预测 - 按产品

  • 概述
  • 2021 年及 2028 年心肺氧合器市场收入份额（按产品划分）
  • 薄膜充氧器
  • 气泡充氧器

第 8 章：北美心肺氧合器市场 - 收入和 2028 年预测 -按应用

  • 概述
  • 心肺氧合器市场收入份额，按类型 2021 年和 2028 年 (%)
  • 心臟
  • 呼吸系统

第 9 章：2028 年北美心肺氧合器市场分析与预测 - 按类型

  • 概述
  • 心肺氧合器市场，按类型 2021 年和 2028 年 (%)
  • 可重复使用的製氧器
  • 免洗机

第 10 章：2028 年北美心肺氧合器市场分析与预测 - 按年龄组

  • 概述
  • 心肺氧合器市场，依年龄层 2021 年和 2028 年 (%)
  • 成年人
  • 儿科
  • 新生儿

第 11 章：北美心肺氧合器市场 - 收入和 2028 年预测 - 按最终用途

  • 概述
  • 心肺氧合器市场收入份额，以最终用途 2021 年和 2028 年 (%)
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 12 章：北美心肺氧合器市场 - 收入和 2028 年预测 - 按国家分析

  • 北美洲

第 13 章：北美心肺氧合器市场-产业格局

  • 概述
  • 心肺氧合器市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 14 章：公司简介

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Nipro Medical Corp
  • MicroPort Scientific Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Chalice Medical Ltd
  • Fresenius Medical Care AG & Co KGaA

第 15 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00028632

The North America Cardiopulmonary Oxygenator Market was valued at US$ 261.35 million in 2022 and is expected to reach US$ 334.51 million by 2028. It is estimated to register a CAGR of 4.2% from 2022 to 2028.

Increasing Surgical Procedures with Surging in Aging Population is Fueling North America Cardiopulmonary Oxygenator Market

Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.

According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.

North America Cardiopulmonary Oxygenator Market Overview

The cardiopulmonary oxygenators market in North America is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the rising prevalence of cardiovascular and respiratory disorders in the region. This has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. For instance, as per American Lung Association, ~12.5 million people are diagnosed with COPD, chronic bronchitis, and emphysema in the US in 2020. Moreover, rising prevalence and incidences of such disorders have increased the number of surgical procedures among large patient population which has fueled the growth of cardiopulmonary oxygenator market. For instance, as per study published by lifespan health system, ~500,00 open heart surgeries are performed in the US every year. Additionally, increase in prevalence of respiratory failure and infectious diseases are further expected to create demand for cardiopulmonary oxygenator.

Furthermore, rising prevalence of cardiovascular disorders are the leading cause of death on the global level and oxygenator can be of great assistance in lifesaving in emergency cases. As per world health organization, ~17.9 million lives are lost due to CVDs annually. Moreover, favorable reimbursement policies are also expected to create ample opportunities for the growth of cardiopulmonary oxygenator. Therefore, rising prevalence and incidence of cardiopulmonary disorders are expected to drive the growth of cardiopulmonary oxygenator market during the forecast period.

North America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiopulmonary Oxygenator Market Segmentation

The North America Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cardiopulmonary Oxygenator market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in North America Cardiopulmonary Oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
  • develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Cardiopulmonary Oxygenator market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Cardiopulmonary Oxygenator Market - by Product
    • 1.3.2 North America Cardiopulmonary Oxygenator Market - by Application
    • 1.3.3 North America Cardiopulmonary Oxygenator Market - by Type
    • 1.3.4 North America Cardiopulmonary Oxygenator Market - by Age Group
    • 1.3.5 North America Cardiopulmonary Oxygenator Market - by End Use
    • 1.3.6 North America Cardiopulmonary Oxygenator Market - by Country

2. North America Cardiopulmonary Oxygenator Market Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Cardiopulmonary Oxygenator Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

Expert's Opinion

5. North America Cardiopulmonary Oxygenators Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Incidence of Cardiopulmonary Diseases
    • 5.1.2 Increasing Surgical Procedures with Surging in Aging Population
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
  • 5.4 Future Trends
    • 5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
  • 5.5 Impact Analysis

6. Cardiopulmonary Oxygenators Market - North America Analysis

  • 6.1 North America Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis

7. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Membrane Oxygenator
    • 7.3.1 Overview
    • 7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Bubble Oxygenator
    • 7.4.1 Overview
    • 7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • 8.3 Cardiac
    • 8.3.1 Overview
    • 8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.3 Acute myocardial infarction
    • 8.3.4 Overview
    • 8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.6 Myocarditis
    • 8.3.7 Overview
    • 8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.9 Post-transplant complication
    • 8.3.10 Overview
    • 8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.12 Decompensated Cardiomyopathy
    • 8.3.13 Overview
    • 8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.15 Others
    • 8.3.16 Overview
    • 8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Respiratory Failure
    • 8.4.4 Overview
    • 8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Acute Respiratory Distress Syndrome
    • 8.4.7 Overview
    • 8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.9 Pulmonary Embolism
    • 8.4.10 Overview
    • 8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.12 Pneumonia
    • 8.4.13 Overview
    • 8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.15 COVID-19
    • 8.4.16 Overview
    • 8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type

  • 9.1 Overview
  • 9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • 9.3 Reusable Oxygenator
    • 9.3.1 Overview
    • 9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Disposable Oxygenator
    • 9.4.1 Overview
    • 9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group

  • 10.1 Overview
  • 10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • 10.3 Adults
    • 10.3.1 Overview
    • 10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Pediatric
    • 10.4.1 Overview
    • 10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Neonates
    • 10.5.1 Overview
    • 10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use

  • 11.1 Overview
  • 11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • 11.3 Hospitals and Clinics
    • 11.3.1 Overview
    • 11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Ambulatory Surgical Centers
    • 11.4.1 Overview
    • 11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis

  • 12.1 North America: Cardiopulmonary Oxygenators Market
    • 12.1.1 Overview
    • 12.1.3 North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
      • 12.1.3.1 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.1 Overview
        • 12.1.3.1.2 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.3 United States: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.1.4 United States: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.1 United States: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.2 United States: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.1.5 United States: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.1.6 United States: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.1.7 United States: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.1 Overview
        • 12.1.3.2.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.3 Canada: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.2.4 Canada: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.1 Canada: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.2 Canada: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.2.5 Canada: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.2.6 Canada: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.2.7 Canada: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.3 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.1 Overview
        • 12.1.3.3.2 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.3 Mexico: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.3.4 Mexico: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.1 Mexico: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.2 Mexico: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.3.5 Mexico: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.3.6 Mexico: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.3.7 Mexico: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)

13. North America Cardiopulmonary Oxygenators Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Getinge AB
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 LivaNova Plc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Medtronic Plc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Terumo Corp
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Nipro Medical Corp
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 MicroPort Scientific Corp
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Braile Biomedica Industry, Commerce and Representations Ltd
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
  • 14.8 Chalice Medical Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Fresenius Medical Care AG & Co KGaA
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. United States Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 2. United States Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 3. United States Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 4. United States Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 5. United States Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 6. United States Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 7. United States Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 8. Canada Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 9. Canada Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 10. Canada Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 11. Canada Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 12. Canada Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 13. Canada Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 14. Canada Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 15. Mexico Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 16. Mexico Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 17. Mexico Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 18. Mexico Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 19. Mexico Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 20. Mexico Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 21. Mexico Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 22. Recent Organic Growth Strategies in North America Cardiopulmonary Oxygenator Market
  • Table 23. Recent Inorganic Growth Strategies in The North America Cardiopulmonary Oxygenator Market
  • Table 24. Glossary of Terms

List Of Figures

  • Figure 1. North America Cardiopulmonary Oxygenator Market Segmentation
  • Figure 2. North America Cardiopulmonary Oxygenator Market, by Country
  • Figure 3. North America Cardiopulmonary Oxygenator Market Overview
  • Figure 4. Membrane Oxygenator Segment Held Largest Share of Product Segment in Cardiopulmonary Oxygenator Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. North America Experts\' Opinion
  • Figure 8. North America Cardiopulmonary Oxygenators Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Cardiopulmonary Oxygenators Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 11. Membrane Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Bubble Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. North America Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • Figure 14. Cardiac: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Acute myocardial infarction: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Myocarditis: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Post-transplant Complication: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Decompensated Cardiomyopathy: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Respiratory: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Respiratory Failure: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Acute Respiratory Distress Syndrome: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Pulmonary Embolism: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pneumonia: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. COVID-19: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. North America Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • Figure 27. Reusable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Disposable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • Figure 30. Adults: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Pediatric: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Neonates: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • Figure 34. Hospitals and Clinics: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Ambulatory Surgical Centers: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Cardiopulmonary Oxygenators Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 38. North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
  • Figure 39. United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 40. Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 41. Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 42. North America Growth Strategies in Cardiopulmonary Oxygenator Market